Project Grant R21AG080592
Award Date
4/1/25
Completion Date
3/31/27
Dollars Obligated
$429K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $309,960 to Northeast Ohio Medical University (Neomed) to conduct research on the role of visual dysfunction in the onset and progression of Alzheimer's disease (AD).
The research aims to uncover novel disease mechanisms arising from visual impairments that could be targeted for early intervention in dementia. Specifically, the project will investigate how the presence of pathological...
The National Institute on Aging (NIA) awarded a $583,558 Project Grant (CFDA 93.866 - Aging Research) to the University of Alabama at Birmingham (UAB) to conduct research on retinal manifestations of Alzheimer's disease (AD). This 12-month project aims to:
Track the earliest disease indicators of AD in the APP/PS1 mouse model through retinal testing.
Define a range of normal retinal function in young and old human subjects.
Evaluate the specificity and sensitivity of retinal tests in...
This Project Grant award of $246,750 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support the development of a novel "pulse-labeling" assay to track the secretion and spreading of extracellular vesicles (EVs) in the brains of mouse models. The goal is to better understand how EVs mediate the transmission of Alzheimer's disease-related proteins like amyloid-beta and tau. The assay will utilize fluorescent EV markers and cell-type specific promoters...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of amyloid-beta 42 (Aβ42) on mitochondrial liquid-liquid phase separation and mitochondrial dysfunction in Alzheimer's disease. The $308,000 award to the Regents of the University of Minnesota will pursue two specific aims: (1) examining the effects of Aβ42 on mitochondrial ribonucleoprotein granule dynamics, and (2) using optogenetic control to study the relationship...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,093,465 to The Washington University to conduct research on the relationship between synaptic activity and the generation and aggregation of amyloid-beta (Aβ) in Alzheimer's disease. The key objectives are to:
Determine the threshold of synaptic activity that causes Aβ to aggregate into soluble oligomers and be released into the brain's interstitial fluid.
Investigate whether...
This $466,531 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by Texas A&M AgriLife Research to investigate the role of the BIN1 protein in oligodendrocytes and its impact on axon integrity. The research aims to provide new insights into how the BIN1 genetic risk factor may relate to the onset and progression of late-onset Alzheimer's disease. The project will utilize oligodendrocyte-specific BIN1 knockout mice and a...
The Project Grant award R01AG079283, funded by the National Institute on Aging (CFDA 93.866 Aging Research program), will support research on the characterization of amyloid protein aggregation and its interactions with apolipoprotein E (APOE) in the context of Alzheimer's disease. The $748,641 award, with a project period from May 2024 to April 2029, will utilize advanced mass spectrometry-based protein footprinting techniques, including hydrogen/deuterium exchange and fast photochemical...
This $766,133 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the mechanisms underlying amyloid-related imaging abnormalities (ARIA) following anti-amyloid immunotherapy for Alzheimer's disease. The University of Texas Health Science Center at Houston is conducting this 5-year study to determine the elimination pathway and clearance mechanism of two conformationally distinct chimeric anti-amyloid antibodies in...
The University of South Florida was awarded a $200,323 Project Grant from the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to investigate the aggregation of amyloid beta (Aβ) peptides during metabolic stress. The two-year grant, starting on September 1, 2024, will utilize a multiscale modeling approach to determine how changes in brain chemistry and physiology, such as pH and ion concentrations, affect the onset and progression of Aβ40 and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $4,151,128 to The Winifred Masterson Burke Medical Research Institute, Inc. to investigate the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the pathogenesis of Alzheimer's disease. The 5-year project, which began on September 1, 2024, aims to elucidate how modifications in brain activity, particularly in the locus coeruleus and hippocampus, can lead to...